176 related articles for article (PubMed ID: 33620128)
1. Synthesis, Characterization, and Inhibition Study of Novel Substituted Phenylureido Sulfaguanidine Derivatives as α-Glycosidase and Cholinesterase Inhibitors.
Akocak S; Taslimi P; Lolak N; Işık M; Durgun M; Budak Y; Türkeş C; Gülçin İ; Beydemir Ş
Chem Biodivers; 2021 Apr; 18(4):e2000958. PubMed ID: 33620128
[TBL] [Abstract][Full Text] [Related]
2. 2-Furoic piperazide derivatives as promising drug candidates of type 2 diabetes and Alzheimer's diseases: In vitro and in silico studies.
Abbasi MA; Hassan M; Ur-Rehman A; Siddiqui SZ; Hussain G; Shah SAA; Ashraf M; Shahid M; Seo SY
Comput Biol Chem; 2018 Dec; 77():72-86. PubMed ID: 30245349
[TBL] [Abstract][Full Text] [Related]
3. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Anticholinergic and Antidiabetic Properties of Some Natural and Synthetic Molecules: An
Çomaklı V; Aygül İ; Sağlamtaş R; Kuzu M; Demirdağ R; Akincioğlu H; Adem Ş; Gülçin İ
Curr Comput Aided Drug Des; 2024; 20(5):441-451. PubMed ID: 37202895
[TBL] [Abstract][Full Text] [Related]
5. Exploring fluorine-substituted piperidines as potential therapeutics for diabetes mellitus and Alzheimer's diseases.
Mughal EU; Hawsawi MB; Naeem N; Hassan A; Alluhaibi MS; Ali Shah SW; Nazir Y; Sadiq A; Alrafai HA; Ahmed SA
Eur J Med Chem; 2024 Jul; 273():116523. PubMed ID: 38795518
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, characterization, inhibition effects, and molecular docking studies as acetylcholinesterase, α-glycosidase, and carbonic anhydrase inhibitors of novel benzenesulfonamides incorporating 1,3,5-triazine structural motifs.
Lolak N; Akocak S; Türkeş C; Taslimi P; Işık M; Beydemir Ş; Gülçin İ; Durgun M
Bioorg Chem; 2020 Jul; 100():103897. PubMed ID: 32413628
[TBL] [Abstract][Full Text] [Related]
7. Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and α-glucosidase inhibitors.
Türkeş C; Akocak S; Işık M; Lolak N; Taslimi P; Durgun M; Gülçin İ; Budak Y; Beydemir Ş
J Biomol Struct Dyn; 2022; 40(19):8752-8764. PubMed ID: 33950796
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, molecular docking, and biological activities of new cyanopyridine derivatives containing phenylurea.
Gezegen H; Gürdere MB; Dinçer A; Özbek O; Koçyiğit ÜM; Taslimi P; Tüzün B; Budak Y; Ceylan M
Arch Pharm (Weinheim); 2021 Apr; 354(4):e2000334. PubMed ID: 33300644
[TBL] [Abstract][Full Text] [Related]
9. In Vitro and Molecular Docking Evaluation of the Anticholinesterase and Antidiabetic Effects of Compounds from
Feunaing RT; Tamfu AN; Gbaweng AJY; Kucukaydin S; Tchamgoue J; Lannang AM; Lenta BN; Kouam SF; Duru ME; Anouar EH; Talla E; Dinica RM
Molecules; 2024 May; 29(11):. PubMed ID: 38893333
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel tris-chalcones as potent carbonic anhydrase, acetylcholinesterase, butyrylcholinesterase and α-glycosidase inhibitors.
Burmaoglu S; Yilmaz AO; Polat MF; Kaya R; Gulcin İ; Algul O
Bioorg Chem; 2019 Apr; 85():191-197. PubMed ID: 30622011
[TBL] [Abstract][Full Text] [Related]
11. meta-Cyanobenzyl substituted benzimidazolium salts: Synthesis, characterization, crystal structure and carbonic anhydrase, α-glycosidase, butyrylcholinesterase, and acetylcholinesterase inhibitory properties.
Türker F; Barut Celepci D; Aktaş A; Taslimi P; Gök Y; Aygün M; Gülçin İ
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800029. PubMed ID: 29963738
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, bioactivity and binding energy calculations of novel 3-ethoxysalicylaldehyde based thiosemicarbazone derivatives.
Ishaq M; Taslimi P; Shafiq Z; Khan S; Ekhteiari Salmas R; Zangeneh MM; Saeed A; Zangeneh A; Sadeghian N; Asari A; Mohamad H
Bioorg Chem; 2020 Jul; 100():103924. PubMed ID: 32442818
[TBL] [Abstract][Full Text] [Related]
13. Synephrine and phenylephrine act as α-amylase, α-glycosidase, acetylcholinesterase, butyrylcholinesterase, and carbonic anhydrase enzymes inhibitors.
Taslimi P; Akıncıoglu H; Gülçin İ
J Biochem Mol Toxicol; 2017 Nov; 31(11):. PubMed ID: 28800181
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological activity and docking calculations of bis-naphthoquinone derivatives from Lawsone.
Riaz MT; Yaqub M; Shafiq Z; Ashraf A; Khalid M; Taslimi P; Tas R; Tuzun B; Gulçin İ
Bioorg Chem; 2021 Sep; 114():105069. PubMed ID: 34134033
[TBL] [Abstract][Full Text] [Related]
15. Biologically active phthalocyanine metal complexes: Preparation, evaluation of α-glycosidase and anticholinesterase enzyme inhibition activities, and molecular docking studies.
Güzel E; Koçyiğit ÜM; Taslimi P; Erkan S; Taskin OS
J Biochem Mol Toxicol; 2021 Jun; 35(6):1-9. PubMed ID: 33704864
[TBL] [Abstract][Full Text] [Related]
16. Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulation.
Ragab A; Salem MA; Ammar YA; Aboulthana WM; Helal MH; Abusaif MS
Drug Dev Res; 2024 Jun; 85(4):e22216. PubMed ID: 38831547
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of garlic-related unsymmetrical thiosulfonates as potential Alzheimer's disease therapeutics: In vitro and in silico study.
Zilbeyaz K; Oztekin A; Kutluana EG
Bioorg Med Chem; 2021 Jun; 40():116194. PubMed ID: 33979775
[TBL] [Abstract][Full Text] [Related]
18. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, biological evaluation, and in silico studies of novel 1,3-diaryltriazene-substituted sulfathiazole derivatives.
Işık M; Akocak S; Lolak N; Taslimi P; Türkeş C; Gülçin İ; Durgun M; Beydemir Ş
Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000102. PubMed ID: 32529657
[TBL] [Abstract][Full Text] [Related]
20. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
Gao H; Jiang Y; Zhan J; Sun Y
Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
